| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8434326 | Cancer Letters | 2018 | 27 Pages |
Abstract
In this review, an extensive literature search is conducted aiming to list drugs with repurposing usage, based on their preferential damage in glioblastoma cells through various mechanisms. Some of these drugs have already entered clinical trials, exhibiting favorable outcomes, which sparks their potential application in glioblastoma treatment.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
João Basso, Ana Miranda, João Sousa, Alberto Pais, Carla Vitorino,